The Role of ANA Positivity in Patients with RA
Nonserious Infection Rates with Biologics Used to Treat RA
20 Years of RA Data: First-Line Biologic & Targeted Synthetic DMARD Trends
Janus Kinase Inhibitors Promising for Difficult-to-Treat RA
Will an App to Monitor Patient Outcomes Improve RA Disease Activity?
RA Shortens Life Expectancy of Patients with RA & Increases Healthcare Costs
Non-Invasive Vagus Nerve Stimulation Tolerated, Effective for Rheumatoid Arthritis
Micromotors Promising for Rheumatoid Arthritis Therapy
Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
- 1
- 2
- 3
- …
- 26
- Next Page »